Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma

BACKGROUND: Previous studies have reported that ARHGEF39 might be frequently upregulated in different cancer types and relevant to cancer progression. However, the expression pattern and clinicopathological features of ARHGEF39 in patients with hepatocellular carcinoma (HCC) needs further exploratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jian, Jia, Wei-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820342/
https://www.ncbi.nlm.nih.gov/pubmed/31626606
http://dx.doi.org/10.12659/MSM.918270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820342/
https://www.ncbi.nlm.nih.gov/pubmed/31626606
http://dx.doi.org/10.12659/MSM.918270

Ejemplares similares